Paradoxical action of growth factors: antiproliferative and proapoptotic signaling by HGF/c-MET. (Q37883394)

24 August 2017

1 reference

title

Paradoxical action of growth factors: antiproliferative and proapoptotic signaling by HGF/c-MET. (English)

1 reference

24 August 2017

Magdalena Dudkowska

2

0 references

author name string

Barbara Grzelakowska-Sztabert

series ordinal

1

1 reference

24 August 2017

language of work or name

1 reference

2 June 2011

1 reference

24 August 2017

published in

Growth Factors Journal

1 reference

24 August 2017

volume

29

1 reference

24 August 2017

issue

4

1 reference

24 August 2017

page(s)

105-118

1 reference

Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Hepatocyte growth factor receptor c-MET is associated with FAS and when activated enhances drug-induced apoptosis in pediatric B acute lymphoblastic leukemia with TEL-AML1 translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Proteolytic cleavages give receptor tyrosine kinases the gift of ubiquity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

EGFR induces expression of IRF-1 via STAT1 and STAT3 activation leading to growth arrest of human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

On the TRAIL to apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

The MET receptor tyrosine kinase in invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Invasive growth: a MET-driven genetic programme for cancer and stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Alternative proteolytic processing of hepatocyte growth factor during wound repair

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

p38 MAPK turns hepatocyte growth factor to a death signal that commits ovarian cancer cells to chemotherapy-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Drug development of MET inhibitors: targeting oncogene addiction and expedience

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Growth Inhibition and Induction of Apoptosis by HGF in Transformed Rat Liver Epithelial Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

HGF-mediated apoptosis via p53/bax-independent pathway activating JNK1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Mechanisms and functions of p38 MAPK signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Dysregulation of Met receptor tyrosine kinase activity in invasive tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Differential signaling by alternative HGF isoforms through c-Met: activation of both MAP kinase and PI 3-kinase pathways is insufficient for mitogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Caspase cleavage of the MET receptor generates an HGF interfering fragment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Phosphorylation of the MET receptor on juxtamembrane tyrosine residue 1001 inhibits its caspase-dependent cleavage.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

JNK signaling in apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Molecular mechanism and biological functions of c-Jun N-terminal kinase signalling via the c-Jun transcription factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Scatter factor protects tumor cells against apoptosis caused by TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Prolonged induction of p21Cip1/WAF1/CDK2/PCNA complex by epidermal growth factor receptor activation mediates ligand-induced A431 cell growth inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Hepatocyte growth factor effects on mesenchymal stem cells: proliferation, migration, and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Amplification of apoptosis through sequential caspase cleavage of the MET tyrosine kinase receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Down-regulation of the met receptor tyrosine kinase by presenilin-dependent regulated intramembrane proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Met receptor tyrosine kinase: enhanced signaling through adapter proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Suramin modulates cellular levels of hepatocyte growth factor receptor by inducing shedding of a soluble form.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

EGF induces cell motility and multi-drug resistance gene expression in breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Lost in transcription: p21 repression, mechanisms, and consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Functional map and domain structure of MET, the product of the c- met protooncogene and receptor for hepatocyte growth factor/scatter factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Normal and malignant prostate epithelial cells differ in their response to hepatocyte growth factor/scatter factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Induction of apoptosis by hepatocyte growth factor/scatter factor and its augmentation by phorbol esters in Meth A cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Novel proapoptotic effect of hepatocyte growth factor: synergy with palmitate to cause pancreatic {beta}-cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Epidermal Growth Factor Induction of Phenotype-dependent Cell Cycle Arrest in Vascular Smooth Muscle Cells Is through the Mitogen-activated Protein Kinase Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Life and death by death receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Hepatocyte growth factor induces redistribution of p21(CIP1) and p27(KIP1) through ERK-dependent p16(INK4a) up-regulation, leading to cell cycle arrest at G1 in HepG2 hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

The Rb/E2F pathway: expanding roles and emerging paradigms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

A functional domain in the heavy chain of scatter factor/hepatocyte growth factor binds the c-Met receptor and induces cell dissociation but not mitogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Surviving cell death through epidermal growth factor (EGF) signal transduction pathways: implications for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Hepatocyte growth factor induces rat ovarian surface epithelial cell mitosis or apoptosis depending on the presence or absence of an extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Degradation of the Met tyrosine kinase receptor by the ubiquitin-proteasome pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through reactive oxygen species-mediated upregulation of death receptor 5 (DR5).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Fibroblast growth factor 2 induces differentiation and apoptosis of Askin tumour cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Coupling of Grb2 to Gab1 mediates hepatocyte growth factor-induced high intensity ERK signal required for inhibition of HepG2 hepatoma cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Crosstalk in Met receptor oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Hepatocyte growth factor enhances death receptor-induced apoptosis by up-regulating DR5

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Hepatocyte growth factor inhibits cell proliferation in vivo of rat hepatocellular carcinomas induced by diethylnitrosamine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Developing c-MET pathway inhibitors for cancer therapy: progress and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Interaction between ERK and GSK3beta mediates basic fibroblast growth factor-induced apoptosis in SK-N-MC neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

NK4 (HGF-antagonist/angiogenesis inhibitor) in cancer biology and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Deletion of the ectodomain unleashes the transforming, invasive, and tumorigenic potential of the MET oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Targeting the tumor and its microenvironment by a dual-function decoy Met receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Functional expression of HGF and HGF receptor/c-met in adult human mesenchymal stem cells suggests a role in cell mobilization, tissue repair, and wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Disassociation of met-mediated biological responses in vivo: the natural hepatocyte growth factor/scatter factor splice variant NK2 antagonizes growth but facilitates metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

JunB suppresses cell proliferation by transcriptional activation of p16(INK4a) expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Targeting the c-Met signaling pathway in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Ab-induced ectodomain shedding mediates hepatocyte growth factor receptor down-regulation and hampers biological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

C-terminal truncated forms of Met, the hepatocyte growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Hepatocyte growth factor sensitizes human ovarian carcinoma cell lines to paclitaxel and cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Mast cell and neutrophil peptidases attack an inactivation segment in hepatocyte growth factor to generate NK4-like antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

The apoptosome: signalling platform of cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Dissociation of heparan sulfate and receptor binding domains of hepatocyte growth factor reveals that heparan sulfate-c-met interaction facilitates signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Angioinhibitory action of NK4 involves impaired extracellular assembly of fibronectin mediated by perlecan-NK4 association.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Inhibition of neoplastic development in the liver by hepatocyte growth factor in a transgenic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

A disintegrin and metalloproteinase-10 (ADAM-10) mediates DN30 antibody-induced shedding of the met surface receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

The kringle 1 domain of hepatocyte growth factor has antiangiogenic and antitumor cell effects on hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

A novel and effective hepatocyte growth factor kringle 1 domain and p53 cocktail viral gene therapy for the treatment of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

CDK inhibitors: positive and negative regulators of G1-phase progression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Hepatocyte growth factor inhibits growth of hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Up-regulation of p21CIP1 expression mediated by ERK-dependent and -independent pathways contributes to hepatocyte growth factor-induced inhibition of HepG2 hepatoma cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Bid stands at the crossroad of stress-response pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

MET receptor tyrosine kinase as a therapeutic anticancer target

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Scatter factor is a fibroblast-derived modulator of epithelial cell mobility

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Celastrol, a triterpene, enhances TRAIL-induced apoptosis through the down-regulation of cell survival proteins and up-regulation of death receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Inhibition of Met/HGF receptor and angiogenesis by NK4 leads to suppression of tumor growth and migration in malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Hepatocyte growth factor has potent anti-proliferative activity in various tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

EGF receptor in relation to tumor development: molecular basis of responsiveness of cancer cells to EGFR-targeting tyrosine kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Structural basis for agonism and antagonism of hepatocyte growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Hepatic stellate cells express the low affinity nerve growth factor receptor p75 and undergo apoptosis in response to nerve growth factor stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

MET signalling: principles and functions in development, organ regeneration and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

High intensity ERK signal mediates hepatocyte growth factor-induced proliferation inhibition of the human hepatocellular carcinoma cell line HepG2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Involvement of down-regulation of Cdk2 activity in hepatocyte growth factor-induced cell cycle arrest at G1 in the human hepatocellular carcinoma cell line HepG2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

The shadow of death on the MET tyrosine kinase receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Proapoptotic function of the MET tyrosine kinase receptor through caspase cleavage

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

"Active" cancer immunotherapy by anti-Met antibody gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Vascular origin of a soluble truncated form of the hepatocyte growth factor receptor (c-met).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

The promise of cancer therapeutics targeting the TNF-related apoptosis-inducing ligand and TRAIL receptor pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

A mechanism of cell survival: sequestration of Fas by the HGF receptor Met.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Basic fibroblast growth factor (bFGF)-induced cell death is mediated through a caspase-dependent and p53-independent cell death receptor pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

NK3 and NK4 of HGF enhance filamin production via STAT pathway, but not NK1 and NK2 in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Engineering the NK1 fragment of hepatocyte growth factor/scatter factor as a MET receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Id proteins in cell cycle control and cellular senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Met decoys: will cancer take the bait?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Promotion of Fas-mediated apoptosis in Type II cells by high doses of hepatocyte growth factor bypasses the mitochondrial requirement

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

Silencing the MET oncogene leads to regression of experimental tumors and metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08977194.2011.585609

10.3109/08977194.2011.585609

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference